Destination therapy: time for real progress
Author:
- 17 June 2008
- journal article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 5 (8) , 477-483
Abstract
Here, Stephen Westaby highlights the promise of new blood pumps in severely symptomatic patients with heart failure, a patient population with very limited treatment options. Both prognosis and quality of life are poor for severely symptomatic patients with stage D heart failure, and treatment options are limited. Few individuals are eligible for cardiac transplantation, and ventricular resynchronization therapy provides only marginal benefit in select patients. The aim of this Review is to highlight the promise of blood pumps in this setting. Circulatory support devices were first developed to act as a bridge to recovery in patients who had failed to wean from cardiopulmonary bypass. As blood pumps developed, they were used to support patients with cardiogenic shock until a donor heart became available. Implantable left ventricular assist devices were then shown to relieve heart failure symptoms and prolong life in patients ineligible for transplant. The limitations of first-generation device technology have meant that the development of an 'off the shelf' solution for advanced heart failure has been slow to progress. New rotary blood pumps already show much promise in this regard but have not yet been subject to rigorous clinical trials. Anecdotal evidence from 7.5 years of event-free survival in the first patient to receive a 'destination' axial flow pump permits justifiable optimism about the future of this approach. It is now time for real progress.Keywords
This publication has 32 references indexed in Scilit:
- Focus on mechanical assist devices for the treatment of heart failureNature Clinical Practice Cardiovascular Medicine, 2008
- Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS ComplexesNew England Journal of Medicine, 2007
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart FailureNew England Journal of Medicine, 2006
- Mechanical Reliability of the Jarvik 2000 HeartThe Annals of Thoracic Surgery, 2006
- The Seattle Heart Failure ModelCirculation, 2006
- Survival of patients removed from the heart transplant waiting listThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity Commentary: Time for a controlled trial?BMJ, 2000
- Improved Mortality and Rehabilitation of Transplant Candidates Treated with a Long-Term Implantable Left Ventricular Assist SystemAnnals of Surgery, 1995